302 related articles for article (PubMed ID: 16234132)
1. Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature.
Uys JD; Niesink RJ
Drug Alcohol Rev; 2005 Jul; 24(4):359-68. PubMed ID: 16234132
[TBL] [Abstract][Full Text] [Related]
2. [A case of acute psychotic episode after a single dose of ecstasy].
Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
[TBL] [Abstract][Full Text] [Related]
3. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
Molero-Chamizo A
Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
[TBL] [Abstract][Full Text] [Related]
4. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
Gouzoulis-Mayfrank E; Daumann J
Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
[TBL] [Abstract][Full Text] [Related]
5. Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine.
Gahlinger PM
Am Fam Physician; 2004 Jun; 69(11):2619-26. PubMed ID: 15202696
[TBL] [Abstract][Full Text] [Related]
6. A brief overview of the clinical pharmacology of "club drugs".
Britt GC; McCance-Katz EF
Subst Use Misuse; 2005; 40(9-10):1189-201. PubMed ID: 16048813
[TBL] [Abstract][Full Text] [Related]
7. Recent trends in the use of "club drugs": an Australian review.
Degenhardt L; Copeland J; Dillon P
Subst Use Misuse; 2005; 40(9-10):1241-56. PubMed ID: 16048815
[TBL] [Abstract][Full Text] [Related]
8. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
9. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
10. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
Karlsen SN; Spigset O; Slørdal L
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):15-24. PubMed ID: 18047478
[TBL] [Abstract][Full Text] [Related]
11. Ecstasy: are animal data consistent between species and can they translate to humans?
Easton N; Marsden CA
J Psychopharmacol; 2006 Mar; 20(2):194-210. PubMed ID: 16510478
[TBL] [Abstract][Full Text] [Related]
12. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
[TBL] [Abstract][Full Text] [Related]
13. [Neuropsychiatric disorders induced by MDMA ("Ecstasy")].
Bailly D
Encephale; 1999; 25(6):595-602. PubMed ID: 10668603
[TBL] [Abstract][Full Text] [Related]
14. A review of the acute subjective effects of MDMA/ecstasy.
Baylen CA; Rosenberg H
Addiction; 2006 Jul; 101(7):933-47. PubMed ID: 16771886
[TBL] [Abstract][Full Text] [Related]
15. MDMA ("ecstasy") abuse as an example of dopamine neuroplasticity.
Schenk S
Neurosci Biobehav Rev; 2011 Apr; 35(5):1203-18. PubMed ID: 21184779
[TBL] [Abstract][Full Text] [Related]
16. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
17. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response.
Green AR; O'shea E; Colado MI
Eur J Pharmacol; 2004 Oct; 500(1-3):3-13. PubMed ID: 15464016
[TBL] [Abstract][Full Text] [Related]
18. Ecstasy (MDMA) and oral health.
Brand HS; Dun SN; Nieuw Amerongen AV
Br Dent J; 2008 Jan; 204(2):77-81. PubMed ID: 18268544
[TBL] [Abstract][Full Text] [Related]
19. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Clemens KJ; McGregor IS; Hunt GE; Cornish JL
Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users.
Stuerenburg HJ; Petersen K; Bäumer T; Rosenkranz M; Buhmann C; Thomasius R
Neuro Endocrinol Lett; 2002 Jun; 23(3):259-61. PubMed ID: 12080289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
